Home
Orbimed Advisors reported a 13.5% stake in Braveheart Bio BRVE · 12,175,159 sh · amendment
Trade details
- Type
- 5% stake report
- Report
- 13D · amendment
- Stake
- 13.5%
- Last report
- 17.2% · filed 26/08/18
- Shares held
- 12,175,159 sh
- Class
- Common Stock
- Stock
- Braveheart Bio BRVE
- Holder
- Orbimed Advisors
- Event date
- 26/09/08
- Filed
- 26/09/10
13.5% stake · −3.7pp from the last report
- Stake
- 13.5%
- Last report
- 17.2%
- Since last report
- −3.7pp
Braveheart Bio trades, last 26 weeks
What else happened in Braveheart Bio around then
Filed or reported within 30 days of the trade day · 08/09~10/08Orbimed Advisors's other 5% stake reports
- Orbimed Advisors
5% stakeElectra Therapeutics
5% stakeElectra Therapeutics
ETRA
11% stake
6,885,170 sh
11% stake
Filed 09/25
- Orbimed Advisors
5% stakeBraveheart Bio
5% stakeBraveheart Bio
BRVE
17.2% stake
12,175,159 sh
17.2% stake
Filed 08/18
- Orbimed Advisors
5% stakeBlossomHill Therapeutics
5% stakeBlossomHill Therapeutics
BLSM
8.9% stake
2,714,279 sh
8.9% stake
Filed 08/18
- Orbimed Advisors
5% stakeWhitehawk Therapeutics
5% stakeWhitehawk Therapeutics
WHWK
7.3% stake
3,934,296 sh
7.3% stake
Filed 08/14
- Orbimed Advisors
5% stakeVistagen Therapeutics
5% stakeVistagen Therapeutics
VTGN
0% stake
0 sh
0% stake
Filed 08/14
